ConductScience.org, home

Paper39201643

CD47 and IFT57 Are Colinear Genes That Are Highly Coexpressed in Most Cancers and Exhibit Parallel Cancer-Specific Correlations with Survival.

Dong K and 5 others. Int J Mol Sci, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. CD47 and IFT57 Are Colinear Genes That Are Highly Coexpressed in Most Cancers and Exhibit Parallel Cancer-Specific Correlations with Survival. Papers, record 39201643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CD47 and IFT57 Are Colinear Genes That Are Highly Coexpressed in Most Cancers and Exhibit Parallel Cancer-Specific Correlations with Survival.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.19, provisional
iCite
Revised in PubMed
2025-08-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dong KKun
2Nihal RRaghibhttps://orcid.org/0009-0003-8340-3621
3Meyer TJThomas J
4Singh SPSatya P
5Kaur SSukhbir
6Roberts DDDavid Dhttps://orcid.org/0000-0002-2481-2981

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD47 AntigenMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Adaptor Proteins, Signal TransducingMajor topic
Humans
Cell Line, Tumor
Gene Expression Profiling
Neoplasms
RNA, Messenger
Thyroid Neoplasms

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Z01 SC009172Intramural NIH HHSUnited StatesZ01SC009172PubMedNIH RePORTER
ZIA SC009172Intramural NIH HHSUnited StatesZIASC009172PubMedNIH RePORTER

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131181609AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer.Cancers (Basel)2019https://conductscience.org/library/papers/31181609PubMed
226840086A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.Oncotarget2016https://conductscience.org/library/papers/26840086PubMed
330643501CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus.Front Immunol2018https://conductscience.org/library/papers/30643501PubMed
421343401Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer.Cancer Res2011https://conductscience.org/library/papers/21343401PubMed
535301709Checkpoint CD47 expression in classical Hodgkin lymphoma.Br J Haematol2022https://conductscience.org/library/papers/35301709PubMed
636882648The DNA damage response pathway regulates the expression of the immune checkpoint CD47.Commun Biol2023https://conductscience.org/library/papers/36882648PubMed
731628526Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.Cancer Immunol Immunother2019https://conductscience.org/library/papers/31628526PubMed
824215318The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.Annu Rev Immunol2014https://conductscience.org/library/papers/24215318PubMed
98864123Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice.Science1996https://conductscience.org/library/papers/8864123PubMed
1024157548Genome engineering using the CRISPR-Cas9 system.Nat Protoc2013https://conductscience.org/library/papers/24157548PubMed
1137796823RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma.PLoS One2023https://conductscience.org/library/papers/37796823PubMed
1217914110A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping.Endocr Relat Cancer2007https://conductscience.org/library/papers/17914110PubMed
1331068700Next-generation characterization of the Cancer Cell Line Encyclopedia.Nature2019https://conductscience.org/library/papers/31068700PubMed
1432043750Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer.Cancer Med2020https://conductscience.org/library/papers/32043750PubMed
1530622229Loss of Primary Cilia Results in the Development of Cancer in the Murine Thyroid Gland.Mol Cells2019https://conductscience.org/library/papers/30622229PubMed
1634079292Silencing HIPPI Suppresses Tumor Progression in Non-Small-Cell Lung Cancer by Inhibiting DNA Replication.Onco Targets Ther2021https://conductscience.org/library/papers/34079292PubMed
177998989Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3.Biochem J1994https://conductscience.org/library/papers/7998989PubMed
1828258703The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.Immunol Rev2017https://conductscience.org/library/papers/28258703PubMed
1931114875GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis.Nucleic Acids Res2019https://conductscience.org/library/papers/31114875PubMed
2025230070Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients.Oncotarget2014https://conductscience.org/library/papers/25230070PubMed

See all 46 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42007973CD47 promotes mitogen-activated protein kinase and epithelial-to-mesenchymal transition molecular programs to drive prometastatic phenotypes in non-small cell lung cancer.Mol Oncol2026https://conductscience.org/library/papers/42007973PubMed
39652550CD47 expression in non-small cell lung cancer and its relationship with tumor-associated macrophage infiltration.PLoS One2024https://conductscience.org/library/papers/39652550PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD47961PubTator's text mininghttps://conductscience.org/library/genes/961NCBI Gene
CRACD57482PubTator's text mininghttps://conductscience.org/library/genes/57482NCBI Gene
IFT5755081PubTator's text mininghttps://conductscience.org/library/genes/55081NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39201643

GET https://conductscience.org/api/papers/v1/39201643/references?page=2